These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1636249

  • 1. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
    Werner M, Maschek H, Kaloutsi V, Choritz H, Georgii A.
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):47-52. PubMed ID: 1636249
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [Abstract] [Full Text] [Related]

  • 4. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
    Gyger M, Infante-Rivard C, D'Angelo G, Forest L, Lussier P.
    Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
    [Abstract] [Full Text] [Related]

  • 6. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
    Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP.
    Blood; 2009 Feb 05; 113(6):1315-25. PubMed ID: 18832655
    [Abstract] [Full Text] [Related]

  • 7. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
    Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD.
    Blood; 1986 Jun 05; 67(6):1765-72. PubMed ID: 3708160
    [Abstract] [Full Text] [Related]

  • 8. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
    Estey EH, Keating MJ, Dixon DO, Trujillo JM, McCredie KB, Freireich EJ.
    Hematol Pathol; 1987 Jun 05; 1(4):203-8. PubMed ID: 3504436
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
    Lewis S, Oscier D, Boultwood J, Ross F, Fitchett M, Rack K, Abrahamson G, Buckle V, Wainscoat JS.
    Am J Hematol; 1995 Jul 05; 49(3):194-200. PubMed ID: 7604812
    [Abstract] [Full Text] [Related]

  • 11. Correlations between cytogenetics and morphology in myelodysplastic syndromes.
    Vila L, Charrin C, Archimbaud E, Treille-Ritouet D, Fraisse J, Felman P, Fiere D, Germain D.
    Blut; 1990 Apr 05; 60(4):223-7. PubMed ID: 2337681
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G, Pelizzari AM, Bellotti D, Tonelli M, Barlati S.
    Leukemia; 2000 Apr 05; 14(4):636-41. PubMed ID: 10764149
    [Abstract] [Full Text] [Related]

  • 14. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
    Solé F, Prieto F, Badia L, Woessner S, Florensa L, Caballin MR, Coll MD, Besses C, Sans-Sabrafen J.
    Cancer Genet Cytogenet; 1992 Nov 05; 64(1):12-20. PubMed ID: 1458444
    [Abstract] [Full Text] [Related]

  • 15. Cytogenetic analysis and RAS mutations in primary myelodysplastic syndromes.
    Plata E, Viniou N, Abazis D, Konstantopoulos K, Troungos C, Vaiopoulos G, Meletis J, Kittas C, Pangalos C, Yataganas X.
    Cancer Genet Cytogenet; 1999 Jun 05; 111(2):124-9. PubMed ID: 10347548
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F, Krauth MT, Vales A, Böhm A, Agis H, Sonneck K, Aichberger KJ, Mayerhofer M, Simonitsch-Klupp I, Müllauer L, Sperr WR, Valent P.
    Leuk Lymphoma; 2006 Mar 05; 47(3):451-60. PubMed ID: 16396768
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
    Oscier DG, Worsley A, Darlow S, Figes A, Williams JD, Hamblin TJ.
    Leuk Res; 1989 Mar 05; 13(9):833-9. PubMed ID: 2796388
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Myelodysplastic syndromes: current diagnosis and classification].
    Tsvetaeva NV, Zavadenko MA, Ol'shanskaia IuV, Glasko EN, Khoroshko ND.
    Ter Arkh; 2001 Mar 05; 73(4):62-6. PubMed ID: 11494452
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.